Clinical Trial Detail

NCT ID NCT02158858
Title A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelodysplastic/Myeloproliferative Neoplasms
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Constellation Pharmaceuticals
Indications

chronic myeloid leukemia

acute leukemia

myelodysplastic/myeloproliferative neoplasm

acute myeloid leukemia

bone marrow cancer

acute lymphocytic leukemia

Therapies

CPI-0610

Age Groups: adult

No variant requirements are available.